These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 31665111

  • 1. Method development for quantitative determination of seven statins including four active metabolites by means of high-resolution tandem mass spectrometry applicable for adherence testing and therapeutic drug monitoring.
    Wagmann L, Hemmer S, Caspar AT, Meyer MR.
    Clin Chem Lab Med; 2020 Apr 28; 58(5):664-672. PubMed ID: 31665111
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery.
    El-Zailik A, Cheung LK, Wang Y, Sherman V, Chow DS.
    J Pharm Biomed Anal; 2019 Feb 05; 164():258-267. PubMed ID: 30396053
    [Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 05; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 4. Liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of simvastatin, lovastatin, atorvastatin, and their major metabolites in human plasma.
    Wang J, Luzum JA, Phelps MA, Kitzmiller JP.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar 01; 983-984():18-25. PubMed ID: 25612772
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May 01; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 6. Chromatography-mass spectrometry methods for the quantitation of statins in biological samples.
    Nirogi R, Mudigonda K, Kandikere V.
    J Pharm Biomed Anal; 2007 Jun 28; 44(2):379-87. PubMed ID: 17433599
    [Abstract] [Full Text] [Related]

  • 7. UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
    Courlet P, Spaggiari D, Desfontaine V, Cavassini M, Alves Saldanha S, Buclin T, Marzolini C, Csajka C, Decosterd LA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep 01; 1125():121733. PubMed ID: 31374423
    [Abstract] [Full Text] [Related]

  • 8. A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry.
    Vethe NT, Munkhaugen J, Andersen AM, Husebye E, Bergan S.
    Ther Drug Monit; 2019 Feb 01; 41(1):19-28. PubMed ID: 30633723
    [Abstract] [Full Text] [Related]

  • 9. Determination of two HMG-CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography-tandem mass spectrometry for pharmaceutical study.
    Deng JW, Kim KB, Song IS, Shon JH, Zhou HH, Liu KH, Shin JG.
    Biomed Chromatogr; 2008 Feb 01; 22(2):131-5. PubMed ID: 17703482
    [Abstract] [Full Text] [Related]

  • 10. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG, Bayne WF.
    Biol Mass Spectrom; 1993 Jan 01; 22(1):1-8. PubMed ID: 8431499
    [Abstract] [Full Text] [Related]

  • 11. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK, Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR.
    Biomed Chromatogr; 2006 Mar 01; 20(3):282-93. PubMed ID: 16143964
    [Abstract] [Full Text] [Related]

  • 12. Hair analysis as a new tool to monitor adherence to long-term therapy to statins.
    Ballotari M, Taus F, Gottardo R, Tagliaro F, Bortolotti F.
    Electrophoresis; 2023 Mar 01; 44(5-6):521-528. PubMed ID: 36640222
    [Abstract] [Full Text] [Related]

  • 13. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG, McBurney CR.
    Pharmacoeconomics; 2003 Mar 01; 21 Suppl 1():13-23. PubMed ID: 12648031
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Mar 01; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 15. Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples.
    Ertürk S, Onal A, Müge Cetin S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug 15; 793(2):193-205. PubMed ID: 12906895
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC-MS/MS.
    Yacoub M, Awwad AA, Alawi M, Arafat T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb 15; 917-918():36-47. PubMed ID: 23369879
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice.
    Russo E, Donato di Paola E, Gareri P, Siniscalchi A, Labate A, Gallelli L, Citraro R, De Sarro G.
    Pharmacol Res; 2013 Apr 15; 70(1):1-12. PubMed ID: 23253428
    [Abstract] [Full Text] [Related]

  • 18. Validation of a novel direct method to determine reduced adherence to atorvastatin therapy.
    Pivoriunas J, Vethe NT, Husebye E, Fagerland MW, Bergan S, Kristiansen O, Munkhaugen J, Sverre E.
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul 16; 10(4):307-315. PubMed ID: 38196131
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determination of statins by gas chromatography - EI/MRM - Tandem mass spectrometry: fermentation of pine samples with Pleurotus ostreatus.
    Sirén H, Kaijanen L, Kaartinen S, Väre M, Riikonen P, Jernström E.
    J Pharm Biomed Anal; 2014 Jun 16; 94():196-202. PubMed ID: 24607418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.